Dengvaxia: Sanofi Admits Dengue Vaccine Poses Health Hazard

An important update from DOH came out on the danger of Dengue Vaccination.

Sanofi, the manufacturer of Dengvaxia, the world’s first dengue vaccine has admitted the drug may be harmful when administered to individuals not previously infected with dengue.


Watsons recently announced the availability of Dengvaxia (dengue vaccination) in select Watsons stores nationwide.

This, for us, is good news. For our household that’s been struck with Dengue twice within a span of five years, we know all too well how deadly this disease can be. Our first Dengue episode was in 2011. Our son was then 6 years old and it was downright traumatic for all of us. Although NS1 test is now readily available practically everywhere, confinement and managing the symptoms of dengue remain to be very crucial.

Because there are four known strains of Dengue and Johns Hopkins discovered a 5th in 2013, my son still isn’t off the hook. His Dengue episode last year (2016), we were actually able to manage through out-patient care. It helped a great deal that we had him NS1 tested, otherwise, we wouldn’t have known early on that it was Dengue. Yes, we can try to manage the fever, get tested to rule it out, but as a mom, I prefer never having to go through the Dengue ordeal altogether. It’s too nerve-racking, the statistics would speak for itself.

Watsons Dengue Vaccine KV 2


The dengue vaccination was launched in the country by the Department of Health (DOH) together with the Department of Education (DepEd), and later on was made available in medical clinics last year. Now, Watsons is the first retailer to offer it in the Philippine market.

“As part of our commitment to improve the lives and health of Filipinos by making health care more accessible to them, we decided to offer dengue vaccination in our select stores nationwide. Dengue is a recurring epidemic in the country, that’s why we recognize the importance of protecting Filipinos against this deadly disease through the vaccination”, says Watsons Trading Health Director, Mr. Danilo Chiong.

The first vaccine against dengue, Dengvaxia, was created by leading multinational pharmaceutical company and an expert in the development of vaccinations, Sanofi Pasteur. The vaccine took more than twenty years to develop and has been thoroughly tested, based on World Health Organization (WHO) guidelines. Studies of the vaccine included more than 41,000 people and were carried out in 15 countries including the Philippines. The results were fully reviewed by a committee of independent experts and has also been recommended by WHO.

Watsons Get Vaccinated Against Dengue Presscon

In the Philippines, the DOH together with DepEd launched the much-awaited administration of the dengue vaccine through school-based immunization approach. This aims to vaccinate about one million Grade 4 pupils aged 9 years old and above enrolled in public schools in several regions of the country.

As of February 2017, the vaccine has been approved in 14 countries where dengue is endemic including Singapore, Mexico, Brazil and the Philippines.

The dengue vaccine has also gotten the endorsement of the Philippine Society for Microbiology and Infectious Diseases (PSMID) and Philippine College of Physicians (PCP).

According to a study by the University of the Philippines National Institute of Health, the vaccine is expected to reduce dengue cases in the country by over 24 percent in a span of five years.

There are more than 200,000 reported dengue cases in the country in 2016 with around 1000 reported cases leading to death.

Besides the health risks, dengue also has an impact on public health costing billions of pesos of tax payers money with treatment costing tens of thousands in pesos per patient.

The dengue vaccination, to be taken in three doses at 0 – 6 – 12 months interval, can protect the individual from all four strains of the dengue virus. This can be administered to people aged 9 to 45 years old.

The dengue vaccination is the latest addition to the vaccines offered by Watsons. It will cost P4000 per dose or P12000 for all 3 doses, which is a reasonable price given the high incidence of dengue and high cost of treatment in the Philippines.

“Watsons also offer Cervical Cancer, Flu and Pneumonia vaccination at scheduled intervals throughout the year. We will have a doctor in store during vaccination dates to administer the vaccination”, adds Mr. Chiong.

Watsons Dengue

Dengue Vaccination (Dengvaxi) Schedule

April 30, 2017 (1st dose)

October 29, 2017 (2nd dose)

April 29, 2018 (3rd dose

May 14, 2017 (1st dose)

November 12, 2017 (2nd dose)

May 13, 2018 (3rd dose)

Dengue Vaccination (Dengvaxia) will be available in more than 100 Watsons stores nationwide. Make sure to take the necessary precautions when it comes to vaccination. Whether it be against Dengue or anything else.



Dengvaxia: Sanofi Admits Dengue Vaccine Poses Health Hazard

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.